ETF Managers Group’s Fulgent Genetics FLGT Stock Holding History

ETF Managers Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$287K	Buy	9,208 +1,869	+25%	+$60.1K	0.01%	547
2022 Q4	$219K	Sell	7,339 -1,592	-18%	-$57K	0.01%	470
2022 Q3	$340K	Sell	8,931 -10,146	-53%	-$509K	0.01%	536
2022 Q2	$1.04M	Buy	19,077 +9,900	+108%	+$544K	0.03%	229
2022 Q1	$575K	Buy	9,177 +161	+2%	+$10.6K	0.01%	446
2021 Q4	$916K	Sell	9,016 -1,750	-16%	-$154K	0.02%	320
2021 Q3	$968K	Buy	10,766 +2,155	+25%	+$196K	0.02%	276
2021 Q2	$824K	Buy	+8,611	New	+$688K	0.01%	286

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

ETF Managers Group's FLGT Position: Q1 2023 in Review

ETF Managers Group increased its Fulgent Genetics (FLGT) stake by 25% in Q1 2023, buying an estimated $60.1K and bringing the position to 9,208 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #547.

ETF Managers Group first reported a position in FLGT in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.04M in Q2 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

ETF Managers Group held 9,208 shares of Fulgent Genetics worth $287K as of Q1 2023.
ETF Managers Group bought 1,869 Fulgent Genetics shares in Q1 2023, an estimated $60.1K.
Fulgent Genetics made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #547 holding.
ETF Managers Group first reported a position in Fulgent Genetics in Q2 2021 and has held it in 8 quarters since.
ETF Managers Group's Fulgent Genetics position peaked at $1.04M in Q2 2022.
215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.